STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era | Zendy

Ahmed ElGuindy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era

Author(s) -

Ahmed ElGuindy

Publication year - 2014

Publication title -

global cardiology science and practice

Language(s) - English

Resource type - Journals

ISSN - 2305-7823

DOI - 10.5339/gcsp.2014.27

Subject(s) - medicine , fibrinolysis , myocardial infarction , cardiology , conventional pci , reperfusion therapy , fibrinolytic therapy , acute st segment elevation myocardial infarction , primary angioplasty , st segment , st elevation , fibrinolytic agent , elevation (ballistics) , percutaneous coronary intervention , tissue plasminogen activator , geometry , mathematics

Data from the Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial(6) and 5-year results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI)(7) are evaluated for further evidence on the effectiveness and safety of a pharmacoinvasive approach for patients presenting with acute ST-segment elevation myocardial infarction (STEMI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research